If you have been reading about GHRH analogue and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-08-17. Numbers and descriptions here follow the published literature rather than marketing material.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, composed of 44 amino acids. It was designed to retain the biological activity of the native hormone while resisting rapid enzymatic degradation. The compound is classified as a growth hormone secretagogue and belongs to the broader family of hypothalamic releasing factors. In research and clinical settings, it is studied for its ability to stimulate pituitary growth hormone release. Its structure includes a modification at the N-terminus that contributes to an extended half-life relative to native growth hormone-releasing hormone.
Tesamorelin binds to growth hormone-releasing hormone receptors on the surface of pituitary somatotroph cells. This binding activates adenylate cyclase, raising intracellular cyclic AMP levels and triggering the release of growth hormone into circulation. The elevated growth hormone then stimulates hepatic production of insulin-like growth factor 1. Because the effect is mediated through the endogenous axis, secretion remains subject to feedback regulation. This distinguishes it from direct growth hormone administration, which bypasses pituitary control entirely.
tesamorelin 是一种人工合成的四十四肽，序列与内源性生长激素释放激素（GHRH）的 1-44 片段一致，区别在于 N 端加接了一个反式-3-己烯酰基。该修饰抑制二肽基肽酶 IV 的快速切割，从而延长分子在循环中的存留时间。作为肽类分子，它难以经胃肠道吸收，文献中讨论的均是注射途径。分类上通常把它归为 GHRH 类似物，以区别于生长激素本身。
作用位置在垂体前叶。tesamorelin 与 GHRH 受体结合后激活腺苷酸环化酶，升高细胞内 cAMP，再经蛋白激酶 A 通路促进生长激素的合成与释放。由于它作用于内源调控节点，生长激素仍以脉冲方式分泌，而不是被持续抬升到固定水平。生长激素随后在肝脏等组织诱导胰岛素样生长因子 1 产生，构成完整的生长激素轴响应。
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Analog of growth hormone-releasing hormone |
| Amino acid length | 44 residues | Matches the native peptide backbone |
| Molecular weight | Approximately 5135 Da | Calculated from the peptide sequence |
| Receptor target | GHRH receptor | Expressed on pituitary somatotroph cells |
| Primary studied use | Visceral fat reduction | Investigated in HIV-associated lipodystrophy |
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
Regulatory approval in the United States came in 2010, when the Food and Drug Administration cleared the peptide for the reduction of excess abdominal fat in adults with HIV infection and associated lipodystrophy. The decision rested mainly on two randomized phase 3 trials that enrolled roughly eight hundred patients and ran for twenty-six weeks. Participants receiving active drug showed substantially greater declines in visceral adipose tissue than those receiving placebo, while total body weight changed comparatively little. A reformulated presentation was later approved, and the product has remained a niche therapy rather than a general weight-loss agent.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, built from 44 amino acids. Its sequence follows the natural human GHRH(1-44) backbone, with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification blocks recognition by dipeptidyl peptidase IV, the enzyme that rapidly truncates the native hormone in circulation. The result is a molecule with a substantially longer plasma residence time than unmodified GHRH, which makes it practical for clinical and laboratory study.
Receptor-level activity begins when the peptide binds the GHRH receptor, a class B G-protein-coupled receptor found on pituitary somatotroph cells. Occupancy triggers Gs-mediated activation of adenylyl cyclase and a rise in intracellular cyclic AMP, which in turn promotes synthesis and pulsatile release of growth hormone. Because the compound acts upstream of the growth hormone axis rather than supplying hormone directly, its effect depends on intact pituitary function. Binding studies in cell culture and animal models have established this pathway; the detailed kinetics of receptor recycling in humans remain less well characterized.
=== Cardiovascular === Adropin also appears to have cardiovascular effects. It has been implicated in the regulation of endothelial function, which is essential for maintaining blood vessel health. Dysfunction in endothelial cells can contribute to conditions such as atherosclerosis and hypertension. Some studies suggest that adropin may have a protective role in cardiovascular health by promoting the dilation of blood vessels and reducing oxidative stress. In mice, adropin regulates cardiac energy metabolism and improves cardiac function and efficiency. In rats, adropin treatment alleviated diabetes related myocardial fibrosis and diastolic dysfunction, and enhanced the therapeutic potential of mesenchymal stem cells in myocardial infarction.
The KRRC Rhodesians were in the forefront of the Allied column pursuing the retreating Axis forces after El Alamein, advancing through Tobruk, Gazala and Benghazi before reaching El Agheila on 24 November 1942. They patrolled around the Axis right flank until being withdrawn to Timimi in December. Tripoli fell to the Eighth Army on 23 January 1943, and six days later Allied forces reached Tunisia's south-eastern frontier, where Italian and German forces manned the Mareth Line, a series of fortifications built by the French in the 1930s.
Before the introduction of complex nutritional supplements and advances in freeze-dried cultures of LAB, winemakers would cultivate their inoculum of lactic acid bacteria from culture slants provided by laboratories. In the 1960s, these winemakers found it easier to create starter cultures in media that contained apple or tomato juice. This "tomato juice factor" was discovered to be a derivative of pantothenic acid, an important growth factor for the bacteria. As with yeast, oxygen can be considered a nutrient for LAB, but only in very small amount and only for microaerophilic species such as O. oeni. However, no evidence exists currently to suggest that malolactic fermentation runs more smoothly in aerobic conditions than in complete anaerobic conditions, and in fact, excessive amounts of oxygen can retard growth of LAB by favoring conditions of competing microbes (such as Acetobacter).
Sources: en.wikipedia.org
== Applications == Because many optically active chemicals such as tartaric acid, are stereoisomers, a polarimeter can be used to identify which isomer is present in a sample – if it rotates polarized light to the left, it is a levo-isomer, and to the right, a dextro-isomer. It can also be used to measure the ratio of enantiomers in solutions. The optical rotation is proportional to the concentration of the optically active substances in solution. Polarimetry may therefore be applied for concentration measurements of enantiomer-pure samples. With a known concentration of a sample, polarimetry may also be applied to determine the specific rotation (a physical property) when characterizing a new substance.
=== Uniforms === Battledress - Used until the 1960s Boots, General Service Khaki drill Denison smock - Used in airborne units until the 1970s 1950 Pattern Jungle Green Dress Boots, Tropical Jungle 1960 Pattern Combat Dress - Produced in olive green and then in Disruptive Pattern Material. Boots, Directly Moulded Sole 1968 Pattern No. 8 Combat Dress - Produced in Disruptive Pattern Material. Smock Parachutist DPM Lightweight Trousers - Produced in olive green No. 9 Tropical Dress 1984 Pattern Combat Dress Boots, Combat, High
John Martin Shaw, Director of Planning and Transportation, Norfolk County Council. For services to Local Government. William Francis Sheridan, Head of International Policy, Forestry Commission. Francis Edward Shields, , lately Chief Executive, National Federation of Young Farmers' Clubs. For services to the Young Farmers Club Movement. Ian Skipper. For charitable services. Brian William Smith, lately Head of Operations, Securities and Investments Board. For services to Financial Regulation. Clifford John Smith. For services to the Newspaper Industry and to the community in Lincolnshire. Dennis Alfred Smith, lately Network Director, Southern Division, Central Office of Information. John Stanley Walter Smith, Head of Corporate Services Group, Her Majesty's Board of Customs and Excise. Neil Durden-Smith. For charitable services. Ian Nelson Sneddon, Chairman, Central Scotland Committee for the Employment of People with Disabilities. For services to the employment of disabled people. Kenneth Speakman, lately Pollution Inspector, Environment Agency. For services to Environmental Protection. Francis Richard Stanhope. For services to the Royal Air Force Association. Robert Russell Steedman, lately Member, Royal Fine Art Commission for Scotland. For services to the Built Environment in Scotland. Susan Elizabeth Stockley, Chairman, National Executive of the National Federation of Women's Institutes. For services to the Women's Institute Movement. John Howard Stoner, Regional General Manager, National Rivers Authority (Welsh Region). For services to the Environment in Wales.
Sources: en.wikipedia.org
It is a synthetic analog of growth hormone-releasing hormone, a hypothalamic peptide. It functions as a growth hormone secretagogue acting at pituitary receptors. The classification separates it from direct growth hormone products.
The synthetic peptide incorporates modifications that slow enzymatic breakdown in circulation. Native growth hormone-releasing hormone is short-lived, whereas the analog is designed for greater stability. The core amino acid backbone is largely retained.
The main studied application is reduction of excess visceral abdominal fat in HIV-associated lipodystrophy. Research has measured fat changes through imaging. Findings concern fat distribution rather than overall body weight.
tesamorelin 属 GHRH 类似物，作用于垂体受体以促进内源生长激素释放；生长激素本身是直接补充的外源激素。两者在给药逻辑、作用位点和反馈调控路径上并不相同。